These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2190901)

  • 21. [Implantable insulin pump: surgical implantation under local anesthesia. (Technical note apropos of 35 cases)].
    Glock Y; Galinier P; Dalous P; Hanaire-Broutin H; Lacombe S; Lafon F; Tauber JP
    Ann Chir; 1992; 46(5):445-9. PubMed ID: 1416757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation-induced alarm and failure of an implanted programmable intrathecal pump.
    Wu H; Wang D
    Clin J Pain; 2007; 23(9):826-8. PubMed ID: 18075412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical use of a totally implantable and programmable pump for the infusion of drugs].
    Balletto N; Cavallini M; Cortesi E; Decian F; Arnone GB; Civalleri D
    Minerva Chir; 1992 May; 47(9):859-65. PubMed ID: 1535696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
    Kongkam P; Wagner DL; Sherman S; Fogel EL; Whittaker SC; Watkins JL; McHenry L; Lehman GA
    Am J Gastroenterol; 2009 May; 104(5):1249-55. PubMed ID: 19367269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps].
    Löchli S; Campbell I; Dorenboos H; Paterson KR; Devlin JG; Hagmüller G; Irsigler K
    Dtsch Med Wochenschr; 1988 Sep; 113(36):1390-3. PubMed ID: 3138098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-controlled analgesia in chronic pain patients: experience with a new device designed to be used with implanted programmable pumps.
    Ilias W; le Polain B; Buchser E; Demartini L;
    Pain Pract; 2008; 8(3):164-70. PubMed ID: 18384501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A promising alternative for the treatment of type I diabetes. The implantable insulin pump].
    Marescaux J; Vix M; Mutter D; Jeandidier N; Boivin S; Pinget M
    Chirurgie; 1993-1994; 119(9):579-84; discussion 584-5. PubMed ID: 7729209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of telemetry and fluidic control system used in the Medstream programmable infusion system: an in vivo and in vitro study.
    Bork T; Crivelli R; Tardy Y; Burger J
    Biomed Microdevices; 2014 Oct; 16(5):779-92. PubMed ID: 24993145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration and maintenance of intravenous insulin infusion in the vapor-pressure powered implantable infusion device.
    Kernstine KH; Kryjeski SR; Ekerholm PA; Wigness BD; Rohde TD; Dorman FD; Buchwald H
    ASAIO Trans; 1988; 34(3):371-4. PubMed ID: 3196535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compact, power-efficient architectures using microvalves and microsensors, for intrathecal, insulin, and other drug delivery systems.
    Li T; Evans AT; Chiravuri S; Gianchandani RY; Gianchandani YB
    Adv Drug Deliv Rev; 2012 Nov; 64(14):1639-49. PubMed ID: 22580183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A programmable and implantable pumping system for systemic chemotherapy: a performance analysis in 52 patients.
    Vogelzang NJ; Ruane M; Ratain MJ; Dhowlatshahi K; Chodak GW
    J Clin Oncol; 1987 Dec; 5(12):1968-76. PubMed ID: 3316517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model of insulin delivery by a controlled release micropump.
    Allen DG; Sefton MV
    Ann Biomed Eng; 1986; 14(3):257-76. PubMed ID: 3767093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The spring-driven implantable pump. A low-cost alternative.
    Wigness BD; Dorman FD; Rohde TD; Buchwald H
    ASAIO J; 1992; 38(3):M454-7. PubMed ID: 1457901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The invention of the programmable implantable medication system.
    Fischell RE
    IEEE Eng Med Biol Mag; 1989; 8(4):65-6. PubMed ID: 18244095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO Micro Infusion Pump: Programmable, Refillable, and Implantable.
    Tan T; Watts SW; Davis RP
    Front Pharmacol; 2011; 2():44. PubMed ID: 21863140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable reservoir for supplemental insulin delivery on demand by external compression.
    Wang PY
    Biomaterials; 1989 Apr; 10(3):197-201. PubMed ID: 2655724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The programmable implantable medication system (PIMS): design features and pre-clinical trials.
    Saudek CD; Fischell RE; Swindle MM
    Horm Metab Res; 1990 Apr; 22(4):201-6. PubMed ID: 2190901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.